• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Seelos Therapeutics, Inc. - Common Stock (NQ:SEEL)

1.280 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Seelos Therapeutics, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
News headline image
Colorado to Vote on Legalizing Psychoactives in November
October 05, 2022
Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the... 
Via PressReach
Topics Supply Chain
News headline image
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll... 
Via PressReach
Topics Cannabis
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,... 
Via FinancialNewsMedia
Topics Cannabis
News headline image
Allied, GH Research Among Top Psychedelic Movers Of Today ↗
October 04, 2022
GAINERS: Allied (OTC:ALID) shares closed up 31.58% at $0.60 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
October 03, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 20.50% at $0.58 
Via Benzinga
News headline image
September Cannabis Category Performances Ranged From -6.3% To -39.0% ↗
October 03, 2022
The performances of the 5 cannabis categories ranged from -6.3% to -39.0% in September, and are now -13.6% to -67.0%, YTD, depending on the category. The S&P 500, in comparison, was -8.6% in September... 
Via Talk Markets
News headline image
Major Psychedelic Stocks Continued To Decline In September ↗
October 02, 2022
There are 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index. Most - but interestingly not all - were down for the week and/or the month. 
Via Talk Markets
News headline image
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
September 30, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 2.08% at $0.49 
Via Benzinga
News headline image
Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗
September 29, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 6.17% at $3.44 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From September 28, 2022 ↗
September 28, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 10.48% at $1.16 
Via Benzinga
News headline image
Biomind Labs, Allied Among Top Psychedelic Movers Of Today ↗
September 27, 2022
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 11.10% at $1.10 
Via Benzinga
News headline image
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
September 26, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.91% at $0.13 
Via Benzinga
News headline image
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD ↗
September 25, 2022
Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From September 22, 2022 ↗
September 22, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.80% at $1.10 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From September 21, 2022 ↗
September 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32 
Via Benzinga
News headline image
Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗
September 20, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.83% at $0.62 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From September 19, 2022 ↗
September 19, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.28% at $0.65 
Via Benzinga
News headline image
The 5 Cannabis Categories Declined Between 3% And 11.5% Last Week ↗
September 19, 2022
The cannabis sector consists of 5 distinctly different categories and they each perform quite differently. 
Via Talk Markets
News headline image
8 Largest Psychedelic Stocks Continued Their Decline Last Week ↗
September 18, 2022
The 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index were collectively down 10% in the past week. We also take a look at some therapy-clinic stocks. 
Via Talk Markets
News headline image
Numinus Wellness, GH Research Among Top Psychedelic Movers Of Today ↗
September 15, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 3.98% at $14.64 
Via Benzinga
News headline image
GH Research, Cybin Among Top Psychedelic Movers Of Today ↗
September 14, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.26% at $13.81 
Via Benzinga
News headline image
Great Psychedelics And Business Events Are Coming In Q4: Check Them Out Here ↗
September 13, 2022
The season for psychedelics conferences is right around the corner. From very large and well-known events to small meets, this year’s remaining months are loaded with on-site and virtual discussions... 
Via Benzinga
News headline image
Biomind Labs, Allied Among Top Psychedelic Movers Of Today ↗
September 12, 2022
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 44.93% at $1.00 
Via Benzinga
News headline image
8 Largest Psychedelic Stocks Dropped Almost 12% This Week ↗
September 10, 2022
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index, while they gained 18.5% in August, declined 11.6% this week. Also, a look into some clinic stocks. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From September 9, 2022 ↗
September 09, 2022
GAINERS: Allied (OTC:ALID) shares closed up 21.78% at $0.52 
Via Benzinga
News headline image
Small Pharma, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
September 08, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 13.39% at $1.27 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From September 7, 2022 ↗
September 07, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.66% at $1.12 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From September 6, 2022 ↗
September 06, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.90% at $0.30 LOSERS: 
Via Benzinga
News headline image
Largest Psychedelic Stocks Up In August; Up 42% Since End Of June ↗
September 04, 2022
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index are on average UP 18.5% in August. 
Via Talk Markets
News headline image
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
September 02, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.41% at $0.29 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap